BarryRCoferMDFACS, FAAP

PubMed

• 1 citations
  Clinical presentation and treatment considerations in children with acute omental torsion: a retrospective review.
  Bianca J Vázquez, Robert Thomas, Jason M. Pfluke, John J. Doski, Barry R. Cofer, Frank M. Robertson, Joseph N. Kidd> ;The American Surgeon. 2010 Apr 1
• 46 citations
  The effect of mid-thoracic VEPTR opening wedge thoracostomy on cervical tilt associated with congenital thoracic scoliosis in patients with thoracic insufficiency synd...
  Robert M. Campbell, Brent M. Adcox, Melvin D. Smith, James W. Simmons, Barry R. Cofer, Stephen Inscore, C. Grohman> ;Spine. 2007 Sep 15
• 8 citations
  Extracorporeal membrane oxygenation in piglets using a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201).
  Gregory B. York, Robert DiGeronimo, Bernard J. Wilson, Barry R. Cofer, Christopher K. Breuer, John D. Josephs, David L. Smith, Donald L. Sorrells> ;Journal of Pediatric Surgery. 2002 Oct 1
• 6 citations
  Spontaneous postnatal resolution of a cystic lung mass: A case report.
  Mary J. Barnes, Donald L. Sorrells, Barry R. Cofer> ;Journal of Pediatric Surgery. 2002 Jun 1
• 22 citations
  Laparoscopic nephrectomy in children.
  G. B. York, F. M. Robertson, Barry R. Cofer, M. D. Bomalaski, S. C. Lynch> ;Surgical Endoscopy. 2000 May 1
• 44 citations
  A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO
  Jeffrey R. Horwitz, Barry R. Cofer, Brad W. Warner, Henry W. Cheu, Kevin P. Lally> ;Journal of Pediatric Surgery. 1998 Nov 1
• 26 citations
  Infantile fibrosarcoma: complete excision is the appropriate treatment.
  Barry R. Cofer, Peter J. Vescio, Eugene S. Wiener> ;Annals of Surgical Oncology. 1996 Mar 1
• 38 citations
  The significant relationship between platelet count and haemorrhagic complications on ECMO
  Anthony Stallion, Barry R. Cofer, Janice A Rafferty, Moritz M. Ziegler, Frederick C. Ryckman> ;Perfusion. 1994 Jul 1
• 25 citations
  Extracorporeal membrane oxygenation in the management of cardiac failure secondary to myocarditis
  Barry R. Cofer, Brad W. Warner, Anthony Stallion, Frederick C. Ryckman> ;Journal of Pediatric Surgery. 1993 May 1
• 24 citations
  Reduced cardiac myofibrillar Mg-ATPase activity without changes in myosin isozymes in patients with end-stage heart failure.
  Adawia A. Alousi, Alison M. Grant, John R. Etzler, Barry R. Cofer, Joanna Van der Bel-Kahn, David B. Melvin> ;Molecular and Cellular Biochemistry. 1990 Jul 17
• Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival.
  Davies, C. B., Madden, R. L., Alexander, J. W., Cofer, B. R., Fisher, R. A., Anderson, P.> ;Transplantation. 1993 May
• Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation.
  Alexander, J. W., Davies, C. B., First, M. R., Cofer, B. R., Munda, R., Madden, R. L., Hariharan, S., Schroeder, T. J.> ;Transplant Proc. 1993 Feb
• Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol re...
  Tchervenkov, J. I., Cofer, B. R., Davies, C., Alexander, J. W.> ;Transplantation. 1995 Mar 27
• Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine.
  Brunson, M. E., Tchervenkov, J. I., Alexander, J. W., Cofer, B. R.> ;Transplant Proc. 1991 Feb
• Donor-specific transfusion and cyclosporine prolong allograft survival when given in the peroperative period.
  Cofer, B. R., Tchervenkov, J. I., Alexander, J. W., Barnwell, S. C.> ;Transplant Proc. 1991 Feb
• Penetrating injury of a duplicated ureter: case report.
  Cofer, B. R., Kaufman, P. N., Nussbaum, M. S., Cirulli, C.> ;J Trauma. 1991 Jan
• Effects of donor-specific transfusion, cyclosporine A and FK 506 on rat cardiac allograft survival.
  Davies, C. B., Cofer, B. R., Alexander, J. W.> ;Transplant Proc. 1991 Dec
• Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney...
  Davies, C. B., Alexander, J. W., Cofer, B. R., First, M. R., Schroeder, T. J.> ;Ann Surg. 1992 Jun
• Effects of pre- and postengraftment donor-specific transfusions and cyclosporine on the enhancement of experimental allograft survival.
  Cofer, B. R., Davies, C. B., Alexander, J. W., Tchervenkov, J. I., Fisher, R. A.> ;J Surg Res. 1992 Jun
• The effect of the prostaglandin analogues misoprostil and enisoprost on the synergy between donor-specific transfusion and cyclosporine in allograft survival.
  Cofer, B. R., Davies, C. B., Alexander, J. W., Tchervenkov, J. I.> ;Transplantation. 1992 Nov
• The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial.
  Alexander, J. W., Babcock, G. F., First, M. R., Davies, C. B., Madden, R. L., Munda, R., Penn, I., Fidler, J. P., Cofer, B. R., Stephens, G.> ;Transplantation. 1992 Feb
• Join now to see all